Advertisement
Advertisement

AKTX

AKTX logo

Akari Therapeutics plc ADR (0.01 USD)

10.76
USD
Sponsored
-1.03
-8.78%
Jun 24, 15:57 UTC -4
Closed
exchange

After-Market

10.83

+0.07
+0.70%

Akari Therapeutics plc ADR (0.01 USD) Profile

About

Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.

Info & Links

CEO

Samir R. Patel

Headquarters

401 EAST JACKSON STREET, SUITE 3300
TAMPA, FL 33602, UNITED KINGDOM

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.akaritx.com

Auditor

BDO USA PC

Share holders

406

Employees

6

Akari Therapeutics plc ADR (0.01 USD) Statistics

Valuation Measures

Market Capitalization2

17.05M

Enterprise Value

14.95M

Enterprise Value/EBITDA(ttm)

-0.51

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.16

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-70.34%

Return on Invested Capital(ttm)

-71.35%

Return on Assets(ttm)

-35.46%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-29.51M

Net Income Available to Common(ttm)

-28.05M

Diluted EPS(ttm)

0.00

Share Statistics

Beta (5Y Monthly)

0.53

52-Week Change

-76.82%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.14B

Dividend Yield

0.00%

Float4

793.00K

% Held by Insiders

30.70%

% Held by Institutions

5.06%

Balance Sheet

Total Cash(mrq)

2.83M

Total Cash Per Share(mrq)

0.00

Total Debt(mrq)

732.00K

Total Debt/Equity(mrq)

2.66%

Current Ratio(mrq)

0.44%

Quick Ratio(mrq)

0.44%

Book Value Per Share(mrq)

25.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-12.56

Free Cash Flow(ytd)

-10.57M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement